,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2016-10-28 04:44:00,Most retirees don't want to spend their Novembers worrying about their investment portfolios.,0.04092976078391075,0.28287646174430847,0.6761937141418457,neutral,-0.24194669723510742
1,2016-10-28 04:44:00,"They have more important things to focus on -- like spending time with family and friends, and preparing for a huge Thanksgiving dinner.",0.11396238207817078,0.03353555127978325,0.8525020480155945,neutral,0.08042682707309723
2,2016-10-28 04:44:00,"If you, too, would like to rest easy this month when it comes to your nest egg, our analysts suggest these three stock buys: pharmaceutical giant GlaxoSmithKline (NYSE: GSK) , Warren Buffett's holding company Berkshire Hathaway (NYSE: BRK-A) (NYSE: BRK-B) , and home improvement leader Home Depot (NYSE: HD) .",0.04108239337801933,0.01972782239317894,0.9391897320747375,neutral,0.021354570984840393
3,2016-10-28 04:44:00,"A shot in the arm for income investors

Sean Williams (GlaxoSmithKline) : Retirees who are looking for a high-yield, low-volatility stock would be wise to consider big pharma stalwart GlaxoSmithKline.",0.1212635338306427,0.018705349415540695,0.8600311279296875,neutral,0.1025581806898117
4,2016-10-28 04:44:00,One of the bigger concerns for GSK in recent years has been the imminent decline in sales of asthma and COPD drug Advair.,0.021654624491930008,0.9555630683898926,0.02278226986527443,negative,-0.9339084625244141
5,2016-10-28 04:44:00,"Advair's patent exclusivity expired a few years ago, but generic versions have yet to hit the market.",0.03545783460140228,0.009303238242864609,0.9552388787269592,neutral,0.026154596358537674
6,2016-10-28 04:44:00,"However, a few are expected within the next three years, and the formerly $8-billion-a-year drug could be generating less than $2 billion a year for the company by 2020.",0.029246652498841286,0.6447854042053223,0.325967937707901,negative,-0.6155387759208679
7,2016-10-28 04:44:00,The good news is that GlaxoSmithKline has made a lot of changes to fortify its future growth prospects.,0.850983202457428,0.013091204687952995,0.13592562079429626,positive,0.8378919959068298
8,2016-10-28 04:44:00,One of the biggest was a transformational asset swap with Novartis that was completed last year.,0.5250807404518127,0.009900565259158611,0.46501871943473816,positive,0.5151801705360413
9,2016-10-28 04:44:00,"GSK sold its small-molecule oncology development platform for $16 billion, acquired Novartis' vaccine operations (minus influenza) for about $7 billion, and the duo formed a joint-venture for their consumer health products divisions.",0.5059385895729065,0.008729346096515656,0.48533207178115845,positive,0.49720925092697144
10,2016-10-28 04:44:00,"These moves helped GSK diversify its revenue stream, and improve its margins and pricing power with all three of its operating segments: pharmaceuticals, vaccines, and consumer health products.",0.952173113822937,0.01671212911605835,0.03111477941274643,positive,0.9354609847068787
11,2016-10-28 04:44:00,New drug launches are another source of growth for GSK.,0.8310725688934326,0.011438172310590744,0.15748924016952515,positive,0.8196343779563904
12,2016-10-28 04:44:00,"The company is the majority owner of ViiV Healthcare, the company behind innovative HIV medicines Triumeq and Tivicay.",0.06826815754175186,0.004719057120382786,0.9270127415657043,neutral,0.06354910135269165
13,2016-10-28 04:44:00,Sales of both drugs have combined to more than double through the first-half of 2016 to $1.4 billion.,0.8985871076583862,0.015362686477601528,0.08605019003152847,positive,0.8832244277000427
14,2016-10-28 04:44:00,"Sales of GSK's next-generation long-lasting COPD and asthma treatments are ramping up, too.",0.9138631820678711,0.013840911909937859,0.07229583710432053,positive,0.9000222682952881
15,2016-10-28 04:44:00,"After a brief period of concern regarding insurer coverage, Breo Ellipta and Anoro are experiencing a sales surge.",0.9442887306213379,0.02255055494606495,0.03316069394350052,positive,0.9217381477355957
16,2016-10-28 04:44:00,"In fact, the gains from new drug growth are eclipsing what GlaxoSmithKline is losing from declining Advair sales.",0.8274207711219788,0.08570051193237305,0.0868786871433258,positive,0.7417202591896057
17,2016-10-28 04:44:00,"With the company sporting a 5.2% yield, more than twice that of the S&P 500 and roughly four times the current rate of inflation, GlaxoSmithKline could be the perfect income stock for retirees to buy now.",0.7025920152664185,0.020457949489355087,0.27695006132125854,positive,0.6821340918540955
18,2016-10-28 04:44:00,"Ride the coattails of the world's greatest investor

Brian Feroldi (Berkshire Hathaway) : This massive conglomerate owns dozens of businesses outright and holds large stakes in many others, a portfolio predominately hand-picked by Warren Buffett.",0.15814419090747833,0.010411471128463745,0.8314443230628967,neutral,0.1477327197790146
19,2016-10-28 04:44:00,"The company's extreme diversification helps to ensure that it can thrive under a wide range of economic conditions, and makes its operations extremely stable.",0.8877277374267578,0.012070177122950554,0.10020210593938828,positive,0.8756575584411621
20,2016-10-28 04:44:00,The bull thesis for buying Berkshire is that the company will continue to produce a huge cash flow that its investment managers will use to acquire more businesses.,0.8558622598648071,0.011977961286902428,0.1321597695350647,positive,0.843884289264679
21,2016-10-28 04:44:00,"This simple formula should propel Berkshire's book value steadily higher over time, providing investors with a great shot at market-beating returns.",0.9337752461433411,0.017719516530632973,0.0485052652657032,positive,0.9160557389259338
22,2016-10-28 04:44:00,"Buffett has openly stated that he would happily buy back shares of Berkshire at 1.2 times book value, because he believes the company's intrinsic value far exceeds that multiple.",0.6538596749305725,0.01967770792543888,0.32646262645721436,positive,0.6341819763183594
23,2016-10-28 04:44:00,"Right now, shares are trading around 1.35 times book value, which suggests that shares are still modestly undervalued.",0.16217410564422607,0.7603421807289124,0.07748377323150635,negative,-0.5981680750846863
24,2016-10-28 04:44:00,That tells me that it is a great time to consider buying a few shares of this iconic business.,0.46983978152275085,0.009653971530497074,0.5205062031745911,neutral,0.46018579602241516
25,2016-10-28 04:44:00,"Brian Stoffel (Home Depot) : Though I agree with Brian that Berkshire Hathaway is a solid choice, I think most great retirement stocks should also have a solid dividend.",0.7378984093666077,0.01882333680987358,0.24327820539474487,positive,0.719075083732605
26,2016-10-28 04:44:00,"Though Home Depot's yield right now -- 2.2% -- might not seem impressive, I think there's lots of room for it to grow.",0.7132130861282349,0.012922195717692375,0.27386474609375,positive,0.7002909183502197
27,2016-10-28 04:44:00,"The key metric for income investors to watch is free cash flow (FCF); this represents the amount of money a company takes in from its normal business, minus any capital expenditures.",0.030597340315580368,0.006649080663919449,0.9627535939216614,neutral,0.02394825965166092
28,2016-10-28 04:44:00,"At the end of the day, it is from FCF that dividends are paid.",0.014714738354086876,0.012380343861877918,0.9729049205780029,neutral,0.0023343944922089577
29,2016-10-28 04:44:00,Here are Home Depot's trends over the past few years.,0.027372607961297035,0.006458422634750605,0.966168999671936,neutral,0.020914185792207718
30,2016-10-28 04:44:00,"There are three key takeaways from this chart:
• Likewise, its dividend has grown steadily -- up an average of 22% per year over the past three years.",0.9568114280700684,0.017325052991509438,0.02586355060338974,positive,0.9394863843917847
31,2016-10-28 04:44:00,• The dividend itself is only eating up 31% of FCF.,0.06669596582651138,0.5072152614593506,0.42608875036239624,negative,-0.4405193030834198
32,2016-10-28 04:44:00,"Such a low payout ratio means that even if the home improvement cycle hits a downturn, Home Depot should have no problem paying its dividend.",0.042073674499988556,0.6712722182273865,0.28665417432785034,negative,-0.6291985511779785
33,2016-10-28 04:44:00,"If, however, business continues to steadily improve, there's no reason to believe its days of dividend growth are over.",0.8933597803115845,0.014454993419349194,0.09218525141477585,positive,0.8789047598838806
34,2016-10-28 04:44:00,"The home improvement industry is highly fragmented, and Home Depot is the top dog with a 24% market share.",0.06372512876987457,0.008391204290091991,0.9278836250305176,neutral,0.05533392354846001
35,2016-10-28 04:44:00,"That means there's still lots of business out there to capture, and it is the best positioned company to do so.",0.7947332859039307,0.013378256000578403,0.19188842177391052,positive,0.7813550233840942
36,2016-10-28 04:44:00,"At the end of the day, you want a retirement portfolio that works for you .",0.03624624013900757,0.008265512995421886,0.9554882645606995,neutral,0.027980726212263107
37,2016-10-28 04:44:00,All three of these companies can do that -- and allow you to focus on what really matters as we head into this holiday season.,0.15548981726169586,0.007048169616609812,0.8374620079994202,neutral,0.1484416425228119
38,2016-10-28 04:44:00,"If you're like most Americans, you're a few years (or more) behind on your retirement savings.",0.05384125933051109,0.10082980990409851,0.8453289270401001,neutral,-0.04698855057358742
39,2016-10-28 04:44:00,"But a handful of little-known ""Social Security secrets"" could help ensure a boost in your retirement income.",0.42587700486183167,0.05124306678771973,0.522879958152771,neutral,0.37463393807411194
40,2016-10-28 04:44:00,"For example: one easy trick could pay you as much as $15,834 more... each year!",0.08638019859790802,0.03199373185634613,0.8816260099411011,neutral,0.05438646674156189
41,2016-10-28 04:44:00,"Once you learn how to maximize your Social Security benefits, we think you could retire confidently with the peace of mind we're all after.",0.35658568143844604,0.011904616840183735,0.6315096616744995,neutral,0.344681054353714
42,2016-10-28 04:44:00,Simply click here to discover how to learn more about these strategies.,0.04130851849913597,0.009173430502414703,0.9495180249214172,neutral,0.03213508799672127
43,2016-10-28 04:44:00,Brian Feroldi has no position in any stocks mentioned.,0.009729471988976002,0.04525366798043251,0.9450168013572693,neutral,-0.03552419692277908
44,2016-10-28 04:44:00,Brian Stoffel has no position in any stocks mentioned.,0.011061043478548527,0.05123596638441086,0.9377029538154602,neutral,-0.040174923837184906
45,2016-10-28 04:44:00,Sean Williams has no position in any stocks mentioned.,0.011434880085289478,0.06792838126420975,0.9206367135047913,neutral,-0.056493502110242844
46,2016-10-28 04:44:00,The Motley Fool owns shares of and recommends Berkshire Hathaway (B shares).,0.02913602814078331,0.011916585266590118,0.9589473605155945,neutral,0.01721944287419319
47,2016-10-28 04:44:00,The Motley Fool recommends Home Depot.,0.055259834975004196,0.045598018914461136,0.8991421461105347,neutral,0.00966181606054306
48,2016-10-28 04:44:00,Try any of our Foolish newsletter services free for 30 days .,0.02325451746582985,0.013860778883099556,0.9628846645355225,neutral,0.009393738582730293
49,2016-10-28 04:44:00,"We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.",0.7942618727684021,0.015105843544006348,0.19063223898410797,positive,0.7791560292243958
50,2016-10-28 04:44:00,The Motley Fool has a disclosure policy .,0.016547100618481636,0.017303917557001114,0.9661489725112915,neutral,-0.0007568169385194778
51,2016-10-28 04:44:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
